Yiwei Zhao

8.5k total citations · 2 hit papers
61 papers, 2.8k citations indexed

About

Yiwei Zhao is a scholar working on Surgery, Pathology and Forensic Medicine and Dermatology. According to data from OpenAlex, Yiwei Zhao has authored 61 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 16 papers in Pathology and Forensic Medicine and 13 papers in Dermatology. Recurrent topics in Yiwei Zhao's work include Spinal Fractures and Fixation Techniques (18 papers), Spine and Intervertebral Disc Pathology (14 papers) and Scoliosis diagnosis and treatment (13 papers). Yiwei Zhao is often cited by papers focused on Spinal Fractures and Fixation Techniques (18 papers), Spine and Intervertebral Disc Pathology (14 papers) and Scoliosis diagnosis and treatment (13 papers). Yiwei Zhao collaborates with scholars based in China, United Kingdom and United States. Yiwei Zhao's co-authors include W.H. Irwin McLean, Haihui Liao, Alan D. Irvine, Simon P. Lee, Frances J.D. Smith, Aileen Sandilands, Ana Terron-Kwiatkowski, David Goudie, Gráinne M. O’Regan and Somnath Mukhopadhyay and has published in prestigious journals such as Nature Genetics, SHILAP Revista de lepidopterología and Diabetes.

In The Last Decade

Yiwei Zhao

52 papers receiving 2.7k citations

Hit Papers

Loss-of-function mutations in the gene encoding filaggrin... 2006 2026 2012 2019 2006 2006 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiwei Zhao China 20 1.9k 1.4k 596 342 319 61 2.8k
Gráinne M. O’Regan Ireland 15 1.9k 1.0× 1.4k 0.9× 532 0.9× 259 0.8× 224 0.7× 30 2.5k
Haihui Liao United Kingdom 18 2.0k 1.0× 1.5k 1.1× 592 1.0× 251 0.7× 391 1.2× 21 2.7k
Yuichiro Tsunemi Japan 26 1.0k 0.5× 557 0.4× 441 0.7× 528 1.5× 147 0.5× 97 1.9k
Kui Young Park South Korea 27 1.7k 0.9× 292 0.2× 243 0.4× 104 0.3× 270 0.8× 189 2.4k
Takahiro Satoh Japan 27 707 0.4× 471 0.3× 466 0.8× 767 2.2× 323 1.0× 129 2.2k
Rachid Tazi‐Ahnini United Kingdom 21 1.2k 0.6× 693 0.5× 236 0.4× 500 1.5× 323 1.0× 38 2.0k
Osamu Nemoto Japan 23 911 0.5× 569 0.4× 307 0.5× 437 1.3× 164 0.5× 57 2.0k
Heidi A. Waldorf United States 20 988 0.5× 236 0.2× 245 0.4× 382 1.1× 116 0.4× 35 1.7k
Ingo Marenholz Germany 20 561 0.3× 612 0.4× 365 0.6× 470 1.4× 1.1k 3.6× 30 2.2k
H. Stege Germany 21 1.2k 0.6× 210 0.1× 130 0.2× 382 1.1× 265 0.8× 59 1.9k

Countries citing papers authored by Yiwei Zhao

Since Specialization
Citations

This map shows the geographic impact of Yiwei Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiwei Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiwei Zhao more than expected).

Fields of papers citing papers by Yiwei Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiwei Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiwei Zhao. The network helps show where Yiwei Zhao may publish in the future.

Co-authorship network of co-authors of Yiwei Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Yiwei Zhao. A scholar is included among the top collaborators of Yiwei Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiwei Zhao. Yiwei Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yiwei, et al.. (2025). An efficient Mo20/SiO2-La transesterification catalyst: The promoting role of La on anti-carbon deposition. Journal of environmental chemical engineering. 13(2). 115485–115485.
3.
Bian, Yanyan, Yiwei Zhao, Yang Yang, et al.. (2024). A Novel growth guidance system for early onset scoliosis: a preliminary in vitro study. Journal of Orthopaedic Surgery and Research. 19(1). 259–259.
5.
Chen, Jie, Qimin Zhou, Shuai Li, et al.. (2024). Metabolic reprogramming driven by METTL1-mediated tRNA m7G modification promotes acquired anlotinib resistance in oral squamous cell carcinoma. Translational research. 268. 28–39. 14 indexed citations
7.
8.
Zhao, Yiwei, et al.. (2022). Interface Engineering of CoO/N-Doped Carbon Nanomaterials as a Bifunctional Electrocatalyst for Rechargeable Zinc-Air Batteries. Journal of The Electrochemical Society. 169(6). 60537–60537. 5 indexed citations
9.
Gordon, Kenneth B., Mark Lebwohl, Kim Papp, et al.. (2021). Long‐term safety of risankizumab from 17 clinical trials in patients with moderate‐to‐severe plaque psoriasis*. British Journal of Dermatology. 186(3). 466–475. 69 indexed citations
10.
Zhao, Yiwei, Suomao Yuan, Yonghao Tian, Lianlei Wang, & Xinyu Liu. (2021). Uniplanar Cannulated Pedicle Screws in the Correction of Lenke Type 1 Adolescent Idiopathic Scoliosis. World Neurosurgery. 149. e785–e793. 4 indexed citations
11.
Morita, Akimichi, Hidetoshi Takahashi, Kentaro Ozawa, et al.. (2020). Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results. The Journal of Dermatology. 48(1). 3–13. 13 indexed citations
12.
Zhao, Yiwei, Jun Jia, Xi Chen, et al.. (2020). Morphologic Changes of Intervertebral Foramen After Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Radiographic and Clinical Study. World Neurosurgery. 142. e151–e159. 5 indexed citations
13.
Morita, Akimichi, Hidetoshi Takahashi, Kentaro Ozawa, et al.. (2019). Twenty‐four‐week interim analysis from a phase 3 open‐label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa. The Journal of Dermatology. 46(9). 745–751. 16 indexed citations
14.
Jia, Jun, Yiwei Zhao, & Xinyu Liu. (2019). Impact of sagittal imbalance correction on clinical outcomes in patients undergoing MIS-TLIF for LSS. Clinical Neurology and Neurosurgery. 181. 119–126. 10 indexed citations
15.
Zhao, Yiwei, Ulrike Gärtner, Frances J.D. Smith, & W.H. Irwin McLean. (2011). Statins Downregulate K6a Promoter Activity: A Possible Therapeutic Avenue for Pachyonychia Congenita. Journal of Investigative Dermatology. 131(5). 1045–1052. 49 indexed citations
16.
Limbergen, Johan Van, Richard K. Russell, Elaine R. Nimmo, et al.. (2009). Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease. Inflammatory Bowel Diseases. 15(10). 1492–1498. 19 indexed citations
17.
18.
Zhao, Yiwei, Hai Lin, Danhua Shen, Yanhua Xuan, & Zhenhua Lin. (2008). Distribution of HPV genotypes in uterine cervical lesions in Yanbian, northern China. Pathology International. 58(10). 643–647. 10 indexed citations
19.
Sandilands, Aileen, Gráinne M. O’Regan, Haihui Liao, et al.. (2006). Prevalent and Rare Mutations in the Gene Encoding Filaggrin Cause Ichthyosis Vulgaris and Predispose Individuals to Atopic Dermatitis. Journal of Investigative Dermatology. 126(8). 1770–1775. 169 indexed citations
20.
Smith, Frances J.D., Alan D. Irvine, Ana Terron-Kwiatkowski, et al.. (2006). Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nature Genetics. 38(3). 337–342. 681 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026